Travis Nemkov
Concepts (611)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 51 | 2025 | 701 | 7.400 |
Why?
| | Blood Preservation | 28 | 2025 | 298 | 3.750 |
Why?
| | Metabolomics | 32 | 2025 | 689 | 3.270 |
Why?
| | Metabolome | 23 | 2023 | 352 | 2.610 |
Why?
| | Hemolysis | 10 | 2025 | 202 | 2.470 |
Why?
| | Blood Donors | 10 | 2025 | 110 | 2.360 |
Why?
| | Glycolysis | 21 | 2025 | 320 | 2.130 |
Why?
| | Erythrocyte Transfusion | 12 | 2025 | 199 | 1.380 |
Why?
| | Drosophila Proteins | 9 | 2025 | 201 | 1.370 |
Why?
| | Drosophila melanogaster | 10 | 2025 | 232 | 1.360 |
Why?
| | Mass Spectrometry | 11 | 2019 | 739 | 1.300 |
Why?
| | High-Throughput Screening Assays | 4 | 2021 | 157 | 1.270 |
Why?
| | Carnitine | 4 | 2024 | 82 | 1.080 |
Why?
| | Hypoxia | 11 | 2024 | 1148 | 1.050 |
Why?
| | Energy Metabolism | 11 | 2024 | 927 | 0.980 |
Why?
| | Amino Acids | 10 | 2023 | 497 | 0.950 |
Why?
| | Oxidative Stress | 14 | 2025 | 1318 | 0.930 |
Why?
| | Animals | 73 | 2025 | 37243 | 0.850 |
Why?
| | Membrane Lipids | 2 | 2021 | 91 | 0.820 |
Why?
| | Proteomics | 8 | 2025 | 1112 | 0.790 |
Why?
| | Shock, Hemorrhagic | 7 | 2020 | 183 | 0.780 |
Why?
| | Mice | 41 | 2025 | 17828 | 0.760 |
Why?
| | Erythroblasts | 1 | 2022 | 19 | 0.750 |
Why?
| | Blood Platelets | 5 | 2025 | 427 | 0.740 |
Why?
| | Athletic Performance | 1 | 2023 | 79 | 0.730 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 4 | 2025 | 31 | 0.720 |
Why?
| | Lipid Metabolism | 6 | 2021 | 523 | 0.690 |
Why?
| | Purines | 4 | 2022 | 179 | 0.690 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 64 | 0.660 |
Why?
| | Physical Exertion | 1 | 2021 | 209 | 0.630 |
Why?
| | Leukemia | 2 | 2019 | 241 | 0.620 |
Why?
| | Hemoglobins | 5 | 2024 | 357 | 0.620 |
Why?
| | Prescription Drugs | 1 | 2021 | 112 | 0.610 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2025 | 285 | 0.600 |
Why?
| | Fatty Acids | 7 | 2024 | 445 | 0.600 |
Why?
| | Iron | 3 | 2025 | 324 | 0.590 |
Why?
| | Carbon | 2 | 2017 | 203 | 0.580 |
Why?
| | Humans | 102 | 2025 | 138972 | 0.580 |
Why?
| | Lymph | 2 | 2016 | 32 | 0.580 |
Why?
| | Cell Death | 1 | 2020 | 375 | 0.570 |
Why?
| | Leukemia, Myeloid, Acute | 7 | 2020 | 633 | 0.560 |
Why?
| | Hypoxanthine | 1 | 2017 | 11 | 0.550 |
Why?
| | Muscle, Skeletal | 9 | 2025 | 1734 | 0.540 |
Why?
| | Anemia | 3 | 2024 | 175 | 0.530 |
Why?
| | Bone Marrow | 1 | 2018 | 299 | 0.520 |
Why?
| | Aging | 8 | 2024 | 1857 | 0.520 |
Why?
| | Altitude Sickness | 5 | 2018 | 148 | 0.490 |
Why?
| | Nitrogen | 1 | 2017 | 165 | 0.490 |
Why?
| | Exercise Tolerance | 3 | 2025 | 278 | 0.480 |
Why?
| | Transfusion Medicine | 1 | 2015 | 13 | 0.480 |
Why?
| | Biomarkers | 10 | 2024 | 4095 | 0.470 |
Why?
| | Oxidation-Reduction | 10 | 2022 | 1076 | 0.460 |
Why?
| | Kynurenine | 5 | 2024 | 115 | 0.460 |
Why?
| | Inflammation | 7 | 2024 | 2853 | 0.450 |
Why?
| | Exercise | 3 | 2023 | 2086 | 0.440 |
Why?
| | Hematopoietic Stem Cells | 3 | 2024 | 409 | 0.440 |
Why?
| | Male | 52 | 2025 | 68250 | 0.440 |
Why?
| | Lipids | 1 | 2019 | 675 | 0.430 |
Why?
| | Receptor, Adenosine A2B | 3 | 2021 | 59 | 0.420 |
Why?
| | Mice, Inbred C57BL | 16 | 2025 | 5801 | 0.400 |
Why?
| | Glucosephosphate Dehydrogenase | 3 | 2025 | 57 | 0.400 |
Why?
| | Mitochondria | 7 | 2025 | 958 | 0.380 |
Why?
| | Taste Buds | 1 | 2015 | 203 | 0.380 |
Why?
| | Healthy Volunteers | 7 | 2021 | 208 | 0.360 |
Why?
| | Neoplastic Stem Cells | 4 | 2021 | 397 | 0.360 |
Why?
| | Extracellular Vesicles | 2 | 2025 | 148 | 0.360 |
Why?
| | Hemorrhage | 2 | 2022 | 747 | 0.360 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2019 | 590 | 0.350 |
Why?
| | Female | 48 | 2025 | 74016 | 0.350 |
Why?
| | Oxygen | 5 | 2020 | 977 | 0.340 |
Why?
| | Adaptation, Physiological | 4 | 2018 | 548 | 0.320 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2021 | 801 | 0.320 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 3 | 2020 | 227 | 0.320 |
Why?
| | Flavones | 2 | 2019 | 11 | 0.310 |
Why?
| | Adult | 28 | 2025 | 38393 | 0.310 |
Why?
| | Sphingosine | 3 | 2023 | 45 | 0.310 |
Why?
| | Altitude | 4 | 2023 | 467 | 0.300 |
Why?
| | Myelodysplastic Syndromes | 2 | 2023 | 141 | 0.300 |
Why?
| | Rats, Sprague-Dawley | 8 | 2020 | 2497 | 0.300 |
Why?
| | Blood Banks | 3 | 2019 | 47 | 0.300 |
Why?
| | Lysophospholipids | 3 | 2023 | 80 | 0.300 |
Why?
| | Adenine | 2 | 2025 | 301 | 0.290 |
Why?
| | Alcohol Oxidoreductases | 2 | 2025 | 61 | 0.280 |
Why?
| | Neoplasm Proteins | 2 | 2025 | 433 | 0.280 |
Why?
| | Polyamines | 3 | 2024 | 42 | 0.280 |
Why?
| | Blood Transfusion | 4 | 2024 | 377 | 0.270 |
Why?
| | Acclimatization | 3 | 2018 | 168 | 0.270 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2025 | 1244 | 0.270 |
Why?
| | Thrombosis | 2 | 2022 | 374 | 0.270 |
Why?
| | RNA-Binding Proteins | 3 | 2023 | 430 | 0.260 |
Why?
| | fms-Like Tyrosine Kinase 3 | 2 | 2017 | 47 | 0.260 |
Why?
| | Hematopoiesis | 2 | 2018 | 193 | 0.260 |
Why?
| | Arginine | 3 | 2024 | 261 | 0.260 |
Why?
| | Proteome | 4 | 2020 | 471 | 0.250 |
Why?
| | Mammals | 3 | 2023 | 285 | 0.250 |
Why?
| | Erythrocyte Aging | 2 | 2024 | 13 | 0.250 |
Why?
| | Sciuridae | 2 | 2019 | 147 | 0.250 |
Why?
| | Gene Expression Regulation, Leukemic | 2 | 2016 | 55 | 0.250 |
Why?
| | Plasma | 3 | 2017 | 220 | 0.250 |
Why?
| | Wounds and Injuries | 3 | 2020 | 834 | 0.250 |
Why?
| | Oxygen Consumption | 4 | 2024 | 710 | 0.250 |
Why?
| | Isotope Labeling | 2 | 2017 | 78 | 0.240 |
Why?
| | Mice, Knockout | 6 | 2025 | 3029 | 0.240 |
Why?
| | Tryptophan | 4 | 2021 | 183 | 0.240 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 475 | 0.240 |
Why?
| | Drosophila | 2 | 2024 | 152 | 0.240 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 177 | 0.240 |
Why?
| | Insulin Resistance | 3 | 2021 | 1222 | 0.240 |
Why?
| | Collagen | 2 | 2020 | 459 | 0.240 |
Why?
| | Erythropoiesis | 2 | 2023 | 56 | 0.230 |
Why?
| | Glycerolphosphate Dehydrogenase | 1 | 2025 | 5 | 0.230 |
Why?
| | Qa-SNARE Proteins | 1 | 2025 | 20 | 0.230 |
Why?
| | Rats | 7 | 2021 | 5591 | 0.230 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 372 | 0.230 |
Why?
| | Coronavirus Infections | 2 | 2020 | 369 | 0.230 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2025 | 126 | 0.230 |
Why?
| | Interleukin-1 | 2 | 2021 | 966 | 0.230 |
Why?
| | Pentose Phosphate Pathway | 4 | 2018 | 53 | 0.230 |
Why?
| | Polymorphism, Genetic | 2 | 2025 | 624 | 0.230 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.220 |
Why?
| | Homeodomain Proteins | 2 | 2020 | 509 | 0.220 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 93 | 0.220 |
Why?
| | Phosphofructokinases | 1 | 2024 | 8 | 0.220 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2024 | 8 | 0.220 |
Why?
| | Hexokinase | 1 | 2024 | 18 | 0.220 |
Why?
| | Rejuvenation | 1 | 2024 | 19 | 0.220 |
Why?
| | Physical Conditioning, Animal | 2 | 2025 | 254 | 0.220 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2018 | 203 | 0.210 |
Why?
| | Cell Line, Tumor | 10 | 2023 | 3397 | 0.210 |
Why?
| | Adenosine Triphosphate | 2 | 2024 | 490 | 0.210 |
Why?
| | Middle Aged | 15 | 2025 | 33782 | 0.210 |
Why?
| | Cardiorespiratory Fitness | 1 | 2024 | 57 | 0.210 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 15 | 0.210 |
Why?
| | Mitochondria, Muscle | 3 | 2021 | 116 | 0.210 |
Why?
| | Blood Group Antigens | 1 | 2023 | 16 | 0.210 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 14 | 0.210 |
Why?
| | Pyruvate Kinase | 1 | 2023 | 26 | 0.210 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1090 | 0.210 |
Why?
| | DNA, Mitochondrial | 1 | 2025 | 208 | 0.210 |
Why?
| | Erythrocyte Deformability | 2 | 2021 | 19 | 0.210 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 210 | 0.210 |
Why?
| | Uric Acid | 1 | 2025 | 165 | 0.210 |
Why?
| | Glutamine | 3 | 2019 | 104 | 0.210 |
Why?
| | Emtricitabine | 1 | 2025 | 204 | 0.210 |
Why?
| | Chromatography, Liquid | 3 | 2025 | 449 | 0.210 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2023 | 29 | 0.210 |
Why?
| | Cerebral Hemorrhage | 1 | 2024 | 113 | 0.200 |
Why?
| | Isoenzymes | 1 | 2024 | 304 | 0.200 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2021 | 46 | 0.200 |
Why?
| | Succinates | 1 | 2023 | 23 | 0.200 |
Why?
| | Larva | 5 | 2025 | 234 | 0.200 |
Why?
| | Oxidative Phosphorylation | 3 | 2018 | 194 | 0.200 |
Why?
| | Tenofovir | 1 | 2025 | 274 | 0.200 |
Why?
| | Lactates | 1 | 2023 | 85 | 0.200 |
Why?
| | Furin | 1 | 2022 | 14 | 0.200 |
Why?
| | Streptococcus pneumoniae | 1 | 2025 | 169 | 0.200 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2024 | 212 | 0.200 |
Why?
| | Pluripotent Stem Cells | 1 | 2023 | 80 | 0.200 |
Why?
| | 2,3-Diphosphoglycerate | 5 | 2023 | 33 | 0.190 |
Why?
| | Down-Regulation | 1 | 2025 | 636 | 0.190 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 258 | 0.190 |
Why?
| | Autophagy | 1 | 2025 | 286 | 0.190 |
Why?
| | Equidae | 1 | 2022 | 7 | 0.190 |
Why?
| | src-Family Kinases | 1 | 2023 | 93 | 0.190 |
Why?
| | Obesity | 5 | 2021 | 2994 | 0.190 |
Why?
| | Histiocytosis | 1 | 2022 | 7 | 0.190 |
Why?
| | Liver | 3 | 2019 | 1807 | 0.190 |
Why?
| | Alleles | 1 | 2025 | 890 | 0.190 |
Why?
| | Bicycling | 1 | 2023 | 114 | 0.190 |
Why?
| | Glucose | 3 | 2017 | 1031 | 0.180 |
Why?
| | Erdheim-Chester Disease | 1 | 2021 | 4 | 0.180 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 112 | 0.180 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2022 | 200 | 0.180 |
Why?
| | Sulfonamides | 3 | 2020 | 505 | 0.180 |
Why?
| | Neutrophils | 2 | 2025 | 1274 | 0.180 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 236 | 0.180 |
Why?
| | Asparagine | 2 | 2018 | 30 | 0.180 |
Why?
| | Transgender Persons | 1 | 2024 | 187 | 0.180 |
Why?
| | Ranitidine | 1 | 2021 | 14 | 0.170 |
Why?
| | Sphingolipids | 2 | 2021 | 77 | 0.170 |
Why?
| | Cholesterol | 2 | 2022 | 403 | 0.170 |
Why?
| | Erythrocyte Count | 1 | 2021 | 21 | 0.170 |
Why?
| | Auditory Pathways | 1 | 2021 | 52 | 0.170 |
Why?
| | Lactic Acid | 5 | 2024 | 303 | 0.170 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 188 | 0.170 |
Why?
| | Protein Domains | 1 | 2022 | 289 | 0.170 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 65 | 0.170 |
Why?
| | Virulence Factors | 1 | 2022 | 160 | 0.170 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 31 | 0.170 |
Why?
| | Syndecan-1 | 1 | 2020 | 36 | 0.170 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 183 | 0.170 |
Why?
| | Testosterone | 1 | 2024 | 402 | 0.170 |
Why?
| | Metformin | 1 | 2024 | 331 | 0.170 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 262 | 0.170 |
Why?
| | Aged | 8 | 2024 | 24172 | 0.170 |
Why?
| | Benzothiazoles | 2 | 2017 | 35 | 0.170 |
Why?
| | Genome-Wide Association Study | 2 | 2024 | 1391 | 0.170 |
Why?
| | Resistance Training | 1 | 2023 | 166 | 0.170 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 94 | 0.170 |
Why?
| | Cell Plasticity | 1 | 2021 | 37 | 0.170 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 84 | 0.160 |
Why?
| | Stromal Cells | 1 | 2020 | 112 | 0.160 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 98 | 0.160 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 125 | 0.160 |
Why?
| | Tandem Mass Spectrometry | 3 | 2025 | 556 | 0.160 |
Why?
| | Cannabidiol | 1 | 2022 | 123 | 0.160 |
Why?
| | Osmotic Pressure | 1 | 2020 | 34 | 0.160 |
Why?
| | Cannabinoids | 1 | 2022 | 168 | 0.160 |
Why?
| | Time Factors | 10 | 2024 | 6869 | 0.160 |
Why?
| | Phenylurea Compounds | 2 | 2017 | 95 | 0.160 |
Why?
| | TCF Transcription Factors | 1 | 2019 | 17 | 0.160 |
Why?
| | Taurine | 1 | 2020 | 40 | 0.160 |
Why?
| | Macrophages | 4 | 2022 | 1543 | 0.160 |
Why?
| | Macrophage Activation | 1 | 2021 | 199 | 0.160 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2019 | 26 | 0.160 |
Why?
| | Phosphatidylserines | 1 | 2020 | 88 | 0.160 |
Why?
| | Transcription Factors | 2 | 2025 | 1701 | 0.160 |
Why?
| | Hibernation | 2 | 2019 | 75 | 0.160 |
Why?
| | Signal Transduction | 8 | 2025 | 5092 | 0.160 |
Why?
| | Shock | 1 | 2020 | 101 | 0.160 |
Why?
| | Parabiosis | 1 | 2019 | 11 | 0.160 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 203 | 0.160 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2021 | 221 | 0.150 |
Why?
| | Hydrogen Peroxide | 1 | 2021 | 332 | 0.150 |
Why?
| | Tryptophan Oxygenase | 2 | 2018 | 34 | 0.150 |
Why?
| | Thyroid Neoplasms | 1 | 2023 | 324 | 0.150 |
Why?
| | Torpor | 1 | 2019 | 14 | 0.150 |
Why?
| | Circadian Clocks | 1 | 2019 | 56 | 0.150 |
Why?
| | Anemia, Sickle Cell | 2 | 2024 | 268 | 0.150 |
Why?
| | Machine Learning | 2 | 2021 | 516 | 0.150 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 910 | 0.150 |
Why?
| | Homeostasis | 2 | 2022 | 614 | 0.150 |
Why?
| | Protein Processing, Post-Translational | 2 | 2018 | 462 | 0.150 |
Why?
| | Cigarette Smoking | 1 | 2020 | 103 | 0.140 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2024 | 557 | 0.140 |
Why?
| | Aspartic Acid | 1 | 2018 | 80 | 0.140 |
Why?
| | Gene-Environment Interaction | 1 | 2020 | 186 | 0.140 |
Why?
| | Hypertension, Pulmonary | 2 | 2021 | 1924 | 0.140 |
Why?
| | Adenosine | 2 | 2017 | 241 | 0.140 |
Why?
| | Blood Specimen Collection | 1 | 2018 | 37 | 0.140 |
Why?
| | Arousal | 1 | 2019 | 156 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 151 | 0.140 |
Why?
| | Renal Insufficiency | 1 | 2020 | 162 | 0.140 |
Why?
| | Transcriptome | 2 | 2021 | 966 | 0.140 |
Why?
| | Stem Cell Niche | 1 | 2018 | 57 | 0.140 |
Why?
| | Vascular Diseases | 1 | 2020 | 240 | 0.140 |
Why?
| | Deamination | 1 | 2017 | 6 | 0.140 |
Why?
| | Proteostasis | 1 | 2018 | 27 | 0.140 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 12 | 0.140 |
Why?
| | Anti-HIV Agents | 1 | 2025 | 836 | 0.140 |
Why?
| | Hemoglobin A | 1 | 2017 | 20 | 0.140 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 18 | 0.140 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4316 | 0.140 |
Why?
| | Cryopreservation | 1 | 2018 | 104 | 0.140 |
Why?
| | Benzeneacetamides | 1 | 2017 | 7 | 0.140 |
Why?
| | Macrophages, Alveolar | 1 | 2021 | 396 | 0.140 |
Why?
| | Diglycerides | 1 | 2018 | 61 | 0.140 |
Why?
| | Glutaminase | 1 | 2017 | 11 | 0.140 |
Why?
| | Calcium | 2 | 2022 | 1188 | 0.140 |
Why?
| | Thiadiazoles | 1 | 2017 | 23 | 0.130 |
Why?
| | Resuscitation | 2 | 2018 | 275 | 0.130 |
Why?
| | Folic Acid Deficiency | 1 | 2017 | 49 | 0.130 |
Why?
| | Nicotine | 1 | 2020 | 347 | 0.130 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 668 | 0.130 |
Why?
| | Immune System | 1 | 2018 | 181 | 0.130 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 20 | 0.130 |
Why?
| | Limit of Detection | 1 | 2017 | 91 | 0.130 |
Why?
| | Basigin | 1 | 2017 | 25 | 0.130 |
Why?
| | Body Fluids | 1 | 2017 | 70 | 0.130 |
Why?
| | Nitriles | 1 | 2018 | 176 | 0.130 |
Why?
| | Young Adult | 8 | 2021 | 13371 | 0.130 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 155 | 0.130 |
Why?
| | Mutation | 6 | 2025 | 3984 | 0.130 |
Why?
| | Citric Acid | 1 | 2016 | 32 | 0.130 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 7 | 0.130 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2138 | 0.130 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 65 | 0.130 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 41 | 0.130 |
Why?
| | Inflammasomes | 1 | 2018 | 133 | 0.130 |
Why?
| | Breast Neoplasms | 2 | 2020 | 2283 | 0.120 |
Why?
| | Neoplasms | 2 | 2022 | 2687 | 0.120 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2025 | 874 | 0.120 |
Why?
| | Folic Acid | 1 | 2017 | 186 | 0.120 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2018 | 333 | 0.120 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 122 | 0.120 |
Why?
| | Brain Death | 1 | 2016 | 46 | 0.120 |
Why?
| | Reperfusion Injury | 1 | 2018 | 288 | 0.120 |
Why?
| | Cognitive Dysfunction | 1 | 2021 | 392 | 0.120 |
Why?
| | Interleukin-6 | 1 | 2020 | 785 | 0.120 |
Why?
| | Diethylhexyl Phthalate | 1 | 2015 | 15 | 0.120 |
Why?
| | Phosphatidylethanolamines | 1 | 2016 | 76 | 0.120 |
Why?
| | Models, Biological | 2 | 2021 | 1810 | 0.120 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2016 | 94 | 0.120 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 154 | 0.120 |
Why?
| | Reactive Oxygen Species | 4 | 2022 | 627 | 0.120 |
Why?
| | Metabolic Flux Analysis | 1 | 2015 | 7 | 0.120 |
Why?
| | Antioxidants | 1 | 2019 | 593 | 0.120 |
Why?
| | Bacteria | 1 | 2022 | 868 | 0.120 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 380 | 0.120 |
Why?
| | Biochemistry | 1 | 2015 | 37 | 0.120 |
Why?
| | Anoikis | 1 | 2015 | 31 | 0.120 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.120 |
Why?
| | Acidosis | 1 | 2016 | 101 | 0.120 |
Why?
| | Fluid Therapy | 1 | 2016 | 137 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 264 | 0.120 |
Why?
| | Glutarates | 2 | 2025 | 10 | 0.120 |
Why?
| | Phosphatidylcholines | 1 | 2016 | 136 | 0.120 |
Why?
| | Vasodilation | 1 | 2018 | 509 | 0.120 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2015 | 56 | 0.110 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 92 | 0.110 |
Why?
| | Immunity, Innate | 1 | 2021 | 825 | 0.110 |
Why?
| | Blood Volume | 1 | 2015 | 65 | 0.110 |
Why?
| | Pandemics | 2 | 2020 | 1645 | 0.110 |
Why?
| | Citrates | 1 | 2014 | 41 | 0.110 |
Why?
| | Platelet Transfusion | 1 | 2015 | 72 | 0.110 |
Why?
| | Cell Proliferation | 5 | 2025 | 2480 | 0.110 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 621 | 0.110 |
Why?
| | Sulfur | 3 | 2022 | 58 | 0.110 |
Why?
| | Extinction, Biological | 1 | 2015 | 36 | 0.110 |
Why?
| | Amyloid beta-Peptides | 1 | 2017 | 230 | 0.110 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 156 | 0.110 |
Why?
| | Mice, Transgenic | 4 | 2025 | 2171 | 0.110 |
Why?
| | Organ Preservation Solutions | 1 | 2014 | 45 | 0.110 |
Why?
| | Cells, Cultured | 5 | 2021 | 4182 | 0.110 |
Why?
| | Linear Models | 1 | 2017 | 855 | 0.110 |
Why?
| | Adipose Tissue | 2 | 2017 | 645 | 0.110 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2017 | 649 | 0.110 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 935 | 0.110 |
Why?
| | Sodium Chloride | 1 | 2014 | 138 | 0.110 |
Why?
| | Health Status | 1 | 2019 | 823 | 0.110 |
Why?
| | Phosphates | 1 | 2014 | 180 | 0.100 |
Why?
| | Methionine | 3 | 2020 | 159 | 0.100 |
Why?
| | Proteolysis | 3 | 2020 | 176 | 0.100 |
Why?
| | Heart Ventricles | 1 | 2018 | 745 | 0.100 |
Why?
| | Peptide Fragments | 1 | 2017 | 694 | 0.100 |
Why?
| | Fetal Development | 1 | 2016 | 298 | 0.100 |
Why?
| | Dietary Supplements | 1 | 2017 | 559 | 0.100 |
Why?
| | Antineoplastic Agents | 3 | 2019 | 2152 | 0.100 |
Why?
| | Glucose Tolerance Test | 3 | 2021 | 366 | 0.100 |
Why?
| | Prognosis | 1 | 2021 | 3995 | 0.100 |
Why?
| | Quantitative Trait Loci | 2 | 2025 | 362 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2516 | 0.100 |
Why?
| | Muscles | 2 | 2023 | 332 | 0.100 |
Why?
| | Nuclear Proteins | 1 | 2017 | 707 | 0.090 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 527 | 0.090 |
Why?
| | Diet | 1 | 2020 | 1285 | 0.090 |
Why?
| | MicroRNAs | 1 | 2018 | 676 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 611 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 792 | 0.090 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 2 | 2025 | 16 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 602 | 0.090 |
Why?
| | Mice, Inbred NOD | 3 | 2017 | 593 | 0.080 |
Why?
| | Microbiota | 1 | 2018 | 760 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2019 | 870 | 0.080 |
Why?
| | Liver Neoplasms | 1 | 2016 | 719 | 0.080 |
Why?
| | Protein Kinase Inhibitors | 3 | 2023 | 907 | 0.080 |
Why?
| | HIV Infections | 1 | 2025 | 2945 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2016 | 1103 | 0.080 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 59 | 0.080 |
Why?
| | Cell Line | 3 | 2022 | 2879 | 0.080 |
Why?
| | Insulin | 2 | 2021 | 2447 | 0.080 |
Why?
| | Bisphosphoglycerate Mutase | 2 | 2021 | 7 | 0.080 |
Why?
| | Phenotype | 4 | 2020 | 3143 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3313 | 0.080 |
Why?
| | Cattle | 2 | 2022 | 990 | 0.080 |
Why?
| | Glucose Clamp Technique | 2 | 2021 | 196 | 0.070 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 859 | 0.070 |
Why?
| | Phosphorylation | 3 | 2018 | 1767 | 0.070 |
Why?
| | Diet, High-Fat | 2 | 2019 | 247 | 0.070 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2020 | 158 | 0.070 |
Why?
| | Adolescent | 3 | 2024 | 21581 | 0.070 |
Why?
| | Brain | 2 | 2021 | 2791 | 0.070 |
Why?
| | Macaca | 2 | 2018 | 64 | 0.070 |
Why?
| | Betacoronavirus | 2 | 2020 | 273 | 0.070 |
Why?
| | Bacterial Proteins | 2 | 2025 | 898 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2021 | 819 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 1742 | 0.070 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2018 | 201 | 0.070 |
Why?
| | Sex Characteristics | 2 | 2023 | 766 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1395 | 0.060 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 45 | 0.060 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 644 | 0.060 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 76 | 0.060 |
Why?
| | Apoptosis | 3 | 2021 | 2551 | 0.060 |
Why?
| | Neurons | 1 | 2015 | 1602 | 0.060 |
Why?
| | Cell Adhesion | 2 | 2018 | 466 | 0.060 |
Why?
| | Molecular Targeted Therapy | 2 | 2019 | 413 | 0.060 |
Why?
| | Mice, Nude | 2 | 2018 | 688 | 0.060 |
Why?
| | Biopsy | 2 | 2020 | 1072 | 0.060 |
Why?
| | Isotonic Solutions | 2 | 2016 | 38 | 0.060 |
Why?
| | Swine | 2 | 2018 | 800 | 0.060 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2025 | 43 | 0.060 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2025 | 57 | 0.060 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2025 | 16 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2025 | 62 | 0.060 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 40 | 0.060 |
Why?
| | Plateletpheresis | 1 | 2024 | 28 | 0.060 |
Why?
| | Deferoxamine | 1 | 2024 | 26 | 0.060 |
Why?
| | Lipid Peroxidation | 1 | 2025 | 152 | 0.060 |
Why?
| | Antimalarials | 1 | 2024 | 32 | 0.060 |
Why?
| | Cell Survival | 2 | 2019 | 1126 | 0.050 |
Why?
| | Alanine | 1 | 2025 | 152 | 0.050 |
Why?
| | RNA Interference | 2 | 2017 | 468 | 0.050 |
Why?
| | Cold Temperature | 2 | 2016 | 188 | 0.050 |
Why?
| | Indoleacetic Acids | 1 | 2024 | 10 | 0.050 |
Why?
| | Glutathione | 2 | 2016 | 357 | 0.050 |
Why?
| | Endothelial Cells | 2 | 2020 | 790 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Organophosphates | 1 | 2025 | 155 | 0.050 |
Why?
| | Blood Glucose | 3 | 2020 | 2241 | 0.050 |
Why?
| | Lipopolysaccharides | 2 | 2018 | 888 | 0.050 |
Why?
| | Respiratory Therapy | 1 | 2023 | 25 | 0.050 |
Why?
| | Pneumococcal Infections | 1 | 2025 | 110 | 0.050 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 626 | 0.050 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2024 | 94 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 134 | 0.050 |
Why?
| | Africa South of the Sahara | 1 | 2023 | 48 | 0.050 |
Why?
| | Pantothenic Acid | 1 | 2023 | 6 | 0.050 |
Why?
| | Puberty | 1 | 2024 | 152 | 0.050 |
Why?
| | Myeloid Cells | 1 | 2024 | 151 | 0.050 |
Why?
| | Prospective Studies | 3 | 2021 | 7661 | 0.050 |
Why?
| | Dasatinib | 1 | 2023 | 56 | 0.050 |
Why?
| | Iodine Radioisotopes | 1 | 2023 | 141 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2023 | 56 | 0.050 |
Why?
| | Hand Strength | 1 | 2023 | 131 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2024 | 190 | 0.050 |
Why?
| | Heme | 1 | 2023 | 77 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2025 | 571 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 76 | 0.050 |
Why?
| | Thrombin | 1 | 2022 | 158 | 0.050 |
Why?
| | Adipocytes | 1 | 2023 | 227 | 0.050 |
Why?
| | Cell Movement | 2 | 2017 | 969 | 0.040 |
Why?
| | Cytokines | 2 | 2022 | 2083 | 0.040 |
Why?
| | Horses | 1 | 2022 | 195 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2022 | 2815 | 0.040 |
Why?
| | Subcellular Fractions | 1 | 2021 | 78 | 0.040 |
Why?
| | Dogs | 1 | 2022 | 425 | 0.040 |
Why?
| | Oncogenes | 1 | 2021 | 118 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 54 | 0.040 |
Why?
| | Candidiasis | 1 | 2021 | 63 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2021 | 112 | 0.040 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2020 | 15 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2022 | 262 | 0.040 |
Why?
| | Immunity | 1 | 2021 | 141 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2021 | 98 | 0.040 |
Why?
| | Cochlea | 1 | 2021 | 70 | 0.040 |
Why?
| | Point Mutation | 1 | 2021 | 238 | 0.040 |
Why?
| | Cystine | 1 | 2020 | 17 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 5744 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2023 | 340 | 0.040 |
Why?
| | Muscle Strength | 1 | 2023 | 320 | 0.040 |
Why?
| | Genome | 1 | 2022 | 299 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2021 | 241 | 0.040 |
Why?
| | Fat Body | 1 | 2020 | 5 | 0.040 |
Why?
| | Creatine | 1 | 2020 | 60 | 0.040 |
Why?
| | Quality of Life | 2 | 2023 | 2962 | 0.040 |
Why?
| | Niacinamide | 1 | 2020 | 82 | 0.040 |
Why?
| | Longevity | 1 | 2021 | 174 | 0.040 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2019 | 4 | 0.040 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 33 | 0.040 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2019 | 20 | 0.040 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2019 | 44 | 0.040 |
Why?
| | Gene Deletion | 1 | 2021 | 389 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2019 | 196 | 0.040 |
Why?
| | Megakaryocytes | 1 | 2019 | 36 | 0.040 |
Why?
| | Phylogeny | 1 | 2023 | 1000 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2019 | 193 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 10 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 10 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2020 | 154 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 186 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 30 | 0.040 |
Why?
| | Platelet Activation | 1 | 2019 | 95 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2020 | 276 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2050 | 0.040 |
Why?
| | Succinic Acid | 1 | 2018 | 41 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 256 | 0.040 |
Why?
| | Interleukin-3 Receptor alpha Subunit | 1 | 2018 | 17 | 0.040 |
Why?
| | Drug Design | 1 | 2019 | 165 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1949 | 0.040 |
Why?
| | Glycerol | 1 | 2018 | 91 | 0.040 |
Why?
| | Acute Disease | 1 | 2021 | 993 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 193 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 570 | 0.040 |
Why?
| | Creatinine | 1 | 2020 | 485 | 0.040 |
Why?
| | Gluconeogenesis | 1 | 2018 | 78 | 0.040 |
Why?
| | Purine Nucleotides | 1 | 2018 | 12 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2021 | 513 | 0.040 |
Why?
| | Methylation | 1 | 2018 | 227 | 0.030 |
Why?
| | Diet, Western | 1 | 2018 | 81 | 0.030 |
Why?
| | Sarcolemma | 1 | 2018 | 42 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2024 | 685 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 370 | 0.030 |
Why?
| | Formic Acid Esters | 1 | 2017 | 3 | 0.030 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 14 | 0.030 |
Why?
| | Crush Injuries | 1 | 2017 | 12 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2591 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 5530 | 0.030 |
Why?
| | Azacitidine | 1 | 2018 | 139 | 0.030 |
Why?
| | Metabolism | 1 | 2017 | 43 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 236 | 0.030 |
Why?
| | Biological Transport | 1 | 2018 | 403 | 0.030 |
Why?
| | Swine, Miniature | 1 | 2017 | 90 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1473 | 0.030 |
Why?
| | Pyrroles | 1 | 2018 | 210 | 0.030 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2017 | 40 | 0.030 |
Why?
| | Caspase 1 | 1 | 2018 | 146 | 0.030 |
Why?
| | Prevalence | 1 | 2024 | 2745 | 0.030 |
Why?
| | Blood Proteins | 1 | 2019 | 244 | 0.030 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 16 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 229 | 0.030 |
Why?
| | Fluorenes | 1 | 2017 | 45 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 22 | 0.030 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 11 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 362 | 0.030 |
Why?
| | Cystathionine | 1 | 2016 | 22 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2850 | 0.030 |
Why?
| | Anaerobiosis | 1 | 2017 | 65 | 0.030 |
Why?
| | Gene Expression | 1 | 2022 | 1487 | 0.030 |
Why?
| | Periodicity | 1 | 2016 | 57 | 0.030 |
Why?
| | Femoral Fractures | 1 | 2017 | 78 | 0.030 |
Why?
| | Weaning | 1 | 2016 | 46 | 0.030 |
Why?
| | Cell Respiration | 1 | 2017 | 103 | 0.030 |
Why?
| | Nucleotides | 1 | 2017 | 128 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 105 | 0.030 |
Why?
| | Proteins | 1 | 2022 | 1009 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 23 | 0.030 |
Why?
| | NADP | 1 | 2016 | 53 | 0.030 |
Why?
| | Quality Control | 1 | 2017 | 173 | 0.030 |
Why?
| | Hydrazines | 1 | 2016 | 36 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 276 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1467 | 0.030 |
Why?
| | Interleukin-18 | 1 | 2018 | 236 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2016 | 50 | 0.030 |
Why?
| | Hydrogen Sulfide | 1 | 2016 | 44 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 82 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2016 | 37 | 0.030 |
Why?
| | Sesquiterpenes | 1 | 2016 | 55 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2018 | 239 | 0.030 |
Why?
| | Least-Squares Analysis | 1 | 2016 | 79 | 0.030 |
Why?
| | Triglycerides | 1 | 2018 | 513 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 129 | 0.030 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2016 | 77 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2017 | 215 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 97 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 599 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 138 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 1093 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 309 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2017 | 159 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 665 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 1002 | 0.030 |
Why?
| | Body Temperature | 1 | 2016 | 223 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 276 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 378 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1317 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 307 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2018 | 265 | 0.030 |
Why?
| | Cysteine | 1 | 2016 | 204 | 0.030 |
Why?
| | Bison | 1 | 2015 | 6 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 255 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 133 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1597 | 0.030 |
Why?
| | Indoles | 1 | 2018 | 411 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2015 | 135 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 216 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1497 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 250 | 0.030 |
Why?
| | Glycosylation | 1 | 2015 | 162 | 0.030 |
Why?
| | Europe | 1 | 2015 | 407 | 0.030 |
Why?
| | Body Size | 1 | 2015 | 103 | 0.030 |
Why?
| | Sirolimus | 1 | 2016 | 277 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 6870 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 368 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 517 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 942 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2018 | 450 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 290 | 0.030 |
Why?
| | Running | 1 | 2017 | 230 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 356 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1192 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2018 | 357 | 0.030 |
Why?
| | Biomedical Research | 1 | 2020 | 695 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1149 | 0.030 |
Why?
| | Seasons | 1 | 2016 | 538 | 0.030 |
Why?
| | Skull | 1 | 2015 | 150 | 0.030 |
Why?
| | Regression Analysis | 1 | 2016 | 1021 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 621 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 501 | 0.030 |
Why?
| | Postpartum Period | 1 | 2016 | 346 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 1031 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1355 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2849 | 0.030 |
Why?
| | Up-Regulation | 1 | 2016 | 852 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1311 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1471 | 0.020 |
Why?
| | Acute Lung Injury | 1 | 2016 | 299 | 0.020 |
Why?
| | Body Mass Index | 1 | 2021 | 2390 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 667 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 449 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3574 | 0.020 |
Why?
| | Athletes | 1 | 2016 | 404 | 0.020 |
Why?
| | Fetus | 1 | 2016 | 800 | 0.020 |
Why?
| | NF-kappa B | 1 | 2015 | 678 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 699 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2159 | 0.020 |
Why?
| | Protein Binding | 1 | 2017 | 2233 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2925 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 10921 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 7685 | 0.020 |
Why?
| | United States | 1 | 2015 | 15074 | 0.010 |
Why?
|
|
Nemkov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|